| ²é¿´: 2077 | »Ø¸´: 22 | ||
cljsͳæ (ÕýʽдÊÖ)
|
[ÇóÖú]
50½ðÇóÒ©Îï½â¹¹
|
|
2012Äê10´óÁÙ´²ºóÆÚ¿¹°©Ò©ÎïÖ® 1: BBI608 2: Talimogene laherparepvec (OncoVex) 3: T-DM1 (trastuzumab emtansine) 4: Zaltrap (aflibercept concentrate) ÇóÒÔÉÏÒ©Îï·Ö×ӽṹ£¬Ç븽ÎÄÏס£¶àл¶àл£¡ |
» ²ÂÄãϲ»¶
081700£¬311£¬Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ4È˻ظ´
²ÄÁÏÓ뻯¹¤371Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
336²ÄÁÏÓ뻯¹¤085600Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏ334Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
331Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ ²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶322
ÒѾÓÐ7È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖúÒ©ÎïΪÄáßò±½Íª
ÒѾÓÐ5È˻ظ´
·ÖÎöÒ©ÎïÖеIJ¬ÊDz»ÊÇÒ»¶¨ÒªÏû½â
ÒѾÓÐ12È˻ظ´
ÎÒÃÇÐèÒªÈÏÕæ¿´ÀàËÆ¡¶ÌìȻҩÎﻯѧ¡·µÄÊéÂð
ÒѾÓÐ20È˻ظ´
Ò©ÎïÌáÈ¡ÎïÔõôŪ³É·Û°¡£¿
ÒѾÓÐ27È˻ظ´
ÆÕ³À¼×öÒ©ÎïÔØÌå
ÒѾÓÐ7È˻ظ´
·Ç¾§Ì¬Ò©ÎïµÄ¸øÒ©Ìåϵ
ÒѾÓÐ4È˻ظ´
̼ÄÉÃ׹ܺÍʯīϩÔÚ200¶È2MPaµÄÌõ¼þÏ£¬Äܳ¤Ê±¼äÎȶ¨Â𣿻ᷢÉú½â¹¹Ö®ÀàµÄ¿ÉÄÜÂð£¿
ÒѾÓÐ9È˻ظ´
¡¾½»Á÷¡¿Çó½ÌXRD¸ßÊÖ°ïæ¿´¿´Õâ·ùͼXRD½â¹¹¾«ÐÞͼÊÇÔõôŪµÄ
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú¡¿50½ð±ÒÇóÖúÒ©ÎﻺÊÍÍ¿²ãµÄ±êÊé
ÒѾÓÐ3È˻ظ´
³ÕÒÄ×ÓÆ¤
°æÖ÷ (ÎÄ̳¾«Ó¢)
ÀÏÆ¦
- PhEPI: 10
- Ó¦Öú: 2016 (½²Ê¦)
- ¹ó±ö: 5.368
- ½ð±Ò: 54487.3
- É¢½ð: 41688
- ºì»¨: 303
- ɳ·¢: 1206
- Ìû×Ó: 32611
- ÔÚÏß: 4303.7Сʱ
- ³æºÅ: 674536
- ×¢²á: 2008-12-14
- ÐÔ±ð: GG
- רҵ: ÎÞÉñÂÛ
- ¹ÜϽ: ÈËÎÄÉç¿Æ
¡ï
xiaoxiao270: ½ð±Ò+1, 3Q 2012-04-25 21:03:10
xiaoxiao270: ½ð±Ò+1, 3Q 2012-04-25 21:03:10
|
2 Chemical Name ICP34.5-, ICP47-deleted herpes simplex virus 1 (HSV-1) incorporating the human GM- CSF gene 3 Chemical Name Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 gamma1-chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer, tetraamide with N2'-[3-[[1-[(4-carboxycyclohexyl)methyl]-2,5-dioxo-3- pyrrolidinyl]thio]-1-oxopropyl]-N2'-deacetylmaytansine »ù±¾Ö»ÓÐÑз¢´úºÅ£¬°®ÄªÄÜÖúÁË¡£ |

2Â¥2012-04-25 18:07:47
cljs
ͳæ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 602.8
- É¢½ð: 52
- ºì»¨: 2
- Ìû×Ó: 497
- ÔÚÏß: 183Сʱ
- ³æºÅ: 555228
- ×¢²á: 2008-05-08
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
3Â¥2012-04-25 18:18:37
³ÕÒÄ×ÓÆ¤
°æÖ÷ (ÎÄ̳¾«Ó¢)
ÀÏÆ¦
- PhEPI: 10
- Ó¦Öú: 2016 (½²Ê¦)
- ¹ó±ö: 5.368
- ½ð±Ò: 54487.3
- É¢½ð: 41688
- ºì»¨: 303
- ɳ·¢: 1206
- Ìû×Ó: 32611
- ÔÚÏß: 4303.7Сʱ
- ³æºÅ: 674536
- ×¢²á: 2008-12-14
- ÐÔ±ð: GG
- רҵ: ÎÞÉñÂÛ
- ¹ÜϽ: ÈËÎÄÉç¿Æ

4Â¥2012-04-25 18:19:47
cljs
ͳæ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 602.8
- É¢½ð: 52
- ºì»¨: 2
- Ìû×Ó: 497
- ÔÚÏß: 183Сʱ
- ³æºÅ: 555228
- ×¢²á: 2008-05-08
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
5Â¥2012-04-25 20:00:09
zzhui
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 462.6
- É¢½ð: 922
- ºì»¨: 3
- Ìû×Ó: 436
- ÔÚÏß: 217.6Сʱ
- ³æºÅ: 266910
- ×¢²á: 2006-07-22
- ÐÔ±ð: GG
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
ÎÒÖ»ÖªµÀµÚÈý¸ö£¬T-DM1¡£2013Äê02ÔÂ22ÈÕÒѾÉÏÊУ¬kadcyla¡£ Õâ¸öÒ©Îï°üÀ¨Èý¸ö²¿·Ö£¬¿¹Ì岿·ÖÊǺÕÈüÍ¡£¬¿¹Her2µ¥¿Ë¡¿¹Ì壻 Ë«¹¦ÄÜÁ¬½Ó¼Á£ºSMCC£¬Õâ¸ö¶«Î÷µÄ»¯Ñ§Ãû³ÆÄã¿ÉÒ԰ٶȵ½¡£ Ò©Îﲿ·Ö£ºDM1£¬ÃÀµÇËØÉúÎï¼îµÄÒ»ÖÖ£¬Î¢¹ÜÒÖÖÆ¼Á¡£ KadcylaÊÇÏȽ«SMCCÁ´½Óµ½ºÕÈüÍ¡ÉÏ£¬Ò»°ãÊÇSMCCÓëÀµ°±ËáµÄ°±»ù½áºÏ£¬È»ºóÔÙ½«DM1Á´½Óµ½ÒѾÁ´½ÓºÃµÄºÕÈüÍ¡-SMCCÉÏ£¬ÒÔÁòÃѼüÏàÁ¬£¬´¿»¯³öÀ´¡£ ÎÒÔÚ×öÕâ¸öÒ©ÎÈç¹ûÓиüºÃµÄÐÅÏ¢£¬¿ÉÒÔÁªÏµÎÒ£¬¹²Í¬·ÖÏí¡£ ![]() |
6Â¥2013-04-14 06:19:01
773621842
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 4604.3
- É¢½ð: 24
- Ìû×Ó: 824
- ÔÚÏß: 132.4Сʱ
- ³æºÅ: 998956
- ×¢²á: 2010-04-17
- ÐÔ±ð: MM
- רҵ: ÁÙ´²·Ö×ÓÉúÎïѧ¼ìÑé
7Â¥2013-05-06 10:28:50
zzhui
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 462.6
- É¢½ð: 922
- ºì»¨: 3
- Ìû×Ó: 436
- ÔÚÏß: 217.6Сʱ
- ³æºÅ: 266910
- ×¢²á: 2006-07-22
- ÐÔ±ð: GG
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ
8Â¥2013-05-09 21:56:11
773621842
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 4604.3
- É¢½ð: 24
- Ìû×Ó: 824
- ÔÚÏß: 132.4Сʱ
- ³æºÅ: 998956
- ×¢²á: 2010-04-17
- ÐÔ±ð: MM
- רҵ: ÁÙ´²·Ö×ÓÉúÎïѧ¼ìÑé
9Â¥2013-05-10 09:50:00
zzhui
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 462.6
- É¢½ð: 922
- ºì»¨: 3
- Ìû×Ó: 436
- ÔÚÏß: 217.6Сʱ
- ³æºÅ: 266910
- ×¢²á: 2006-07-22
- ÐÔ±ð: GG
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ
10Â¥2013-05-12 15:58:37














»Ø¸´´ËÂ¥
ľÓС£PharmaprojectsÊý¾Ý¿â²éµÄ 